ImmunoGen cancer treatment application gets another chance

29-03-2022

Alex Baldwin

ImmunoGen cancer treatment application gets another chance

ESB Professional / Shutterstock.com

ImmunoGen has been given the go-ahead to revive its patent application for a cancer treatment dosage following a Federal Circuit ruling on Friday.


ImmunoGen, US Court of Appeals for the Federal Circuit, mirvetusimab, USPTO, big pharma

LSIPR